New Trends in Hepatocellular Carcinoma: Artificial Intelligence, Robotics and Innovative Treatments
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 376
Special Issue Editor
Special Issue Information
Dear Colleagues,
Hepatocellular carcinoma is a worldwide issue, and treatment has rapidly evolved in the recent years. Its prevalence and aetiology vary in different countries, but the incidence is increasing worldwide. Treatment and strategies are complex, with a wide range of medical and surgical solutions often combined, but frequently used differently and in different fashions according to countries, regions, hospitals, and even medical teams. These variations reflect the combined presence of a complex neoplastic disease almost constantly associated with cirrhosis, necessitating a single strategy to treat two diseases at a time. Evolutions in immunotherapy and chemotherapy, technical innovations such as the R.A.P.I.D. technique in liver transplantation, the use of indocyanine green during liver resection, the progressive widespread of robotics, and the emerging role of artificial intelligence are changing the standard paradigms and opening new frontiers to future developments. The real benefits of these innovations are still under investigation, but precision medicine and precision surgery has become a cornerstone concept in the management of the disease. In this Special Issue, we aim to present the most recent advances and innovations in the management of hepatocellular carcinoma, in order to understand the most important trends and future directions.
Dr. Emanuele Felli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatocellular carcinoma
- innovations
- future trends
- robotics
- artificial intelligence
